| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |